You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

BRCA 2

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Germline Variant Carriers With BRCA1 or BRCA2

Recruiting
  • BRCA1 and/or BRCA2 Variant Carriers
  • +3 more
    • Okayama, Japan
      Okayama University
    Dec 25, 2022

    Breast Cancer, Genetic Disease, BRCA2 Mutation Trial (blood sample for BRCA2 mutation detection)

    Not yet recruiting
    • Breast Cancer
    • +2 more
    • blood sample for BRCA2 mutation detection
    • (no location specified)
    Jun 1, 2023

    BRCA1/2 Flu Vaccine

    Active, not recruiting
    • BRCA1 Mutation
    • BRCA2 Mutation
    • Seasonal influenza vaccine
    • Philadelphia, Pennsylvania
      University of Pennsylvania
    Aug 16, 2022

    BRCA1 Mutation, BRCA2 Mutation, Ovarian Cancer Trial in Providence (Talazoparib Oral Capsule)

    Active, not recruiting
    • BRCA1 Mutation
    • +4 more
    • Talazoparib Oral Capsule
    • Providence, Rhode Island
    • +1 more
    Nov 30, 2022

    Breast Cancer, Metastatic Breast Cancer, BRCA1 Gene Mutation Trial in Boston (ABT-888, temozolomide)

    Active, not recruiting
    • Breast Cancer
    • +3 more
    • Boston, Massachusetts
    • +2 more
    Dec 21, 2022

    Triple Negative Breast Tumors, Triple Negative Breast Cancer, Breast Tumors Trial (Pembrolizumab, Paclitaxel, Carboplatin)

    Not yet recruiting
    • Triple Negative Breast Neoplasms
    • +7 more
    • (no location specified)
    Aug 1, 2022

    Endocrine Disruptors and Life STILe in Breast Cancer Development

    Recruiting
    • Breast Cancer
    • +5 more
      • Roma, Italy
        Alessandra Fabi
      Feb 25, 2023

      Metastatic Solid Tumor, BRCA1 Mutation, BRCA2 Mutation Trial in San Francisco (Niraparib, Irinotecan)

      Not yet recruiting
      • Metastatic Solid Tumor
      • +4 more
      • San Francisco, California
        University of California, San Francisco
      Jan 12, 2023

      BRCA1 Gene Mutation, BRCA2 Gene Mutation, Ovarian Serous Adenocarcinoma Trial in Buffalo, New York (biological, other, drug)

      Active, not recruiting
      Has Results
      • BRCA1 Gene Mutation
      • +5 more
      • Durvalumab
      • +3 more
      • Buffalo, New York
      • +1 more
      Jan 20, 2023

      PREDICTION OF GERMLINE BRCA 1/2 GENES FROM HEALTHY OVARIES

      Not yet recruiting
      • BRCA Mutation
      • +2 more
      • Germinal BRCA
      • (no location specified)
      Mar 3, 2023

      Stage I Breast Cancer, Stage II Breast Cancer, Stage III Breast Cancer Trial in United States (Niraparib, Dostarlimab)

      Recruiting
      • Stage I Breast Cancer
      • +7 more
      • Baltimore, Maryland
      • +6 more
      Nov 11, 2022

      Germline BRCA1 and BRCA2 Mutations in Jewish Women Affected by

      Completed
      • Breast Cancer
      • Blood test
      • Questionnaire
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      Dec 27, 2021

      Prostate Cancer, BRCA1 Mutation, BRCA2 Mutation Trial (Olaparib, LHRH agonist)

      Not yet recruiting
      • Prostate Cancer
      • +4 more
      • (no location specified)
      Aug 10, 2022

      Breast Cancer, Ovarian Cancer, Pancreas Cancer Trial (TNG348, Olaparib)

      Not yet recruiting
      • Breast Cancer
      • +7 more
      • (no location specified)
      Sep 26, 2023

      BRCA1 Gene Mutation, BRCA2 Gene Mutation Trial in Columbus (Informational Intervention, Survey Administration)

      Recruiting
      • BRCA1 Gene Mutation
      • BRCA2 Gene Mutation
      • Informational Intervention
      • Survey Administration
      • Columbus, Ohio
        Ohio State University Comprehensive Cancer Center
      Mar 2, 2022

      Advanced Breast Cancer, HER2/Neu Negative, Triple-Negative Breast Cancer Trial in Stanford (Talazoparib Tosylate)

      Active, not recruiting
      • Advanced Breast Cancer
      • +2 more
      • Talazoparib Tosylate
      • Stanford, California
        Stanford University Hospitals and Clinics
      Nov 16, 2022

      TNBC - Triple-Negative Breast Cancer, BRCA1 Mutation, BRCA2 Mutation Trial (olaparib, Durvalumab)

      Not yet recruiting
      • TNBC - Triple-Negative Breast Cancer
      • +2 more
      • (no location specified)
      Jan 12, 2022

      BRCA and NACT in TNBC Patients

      Completed
      • Triple-Negative Breast Cancer
      • BRCA1/2 genetic testing
      • Rome, RM, Italy
        Fondazione Policlinico Universitario Agostino Gemelli IRCCS
      Feb 20, 2023

      Breast Cancer, Ovarian Cancer, Breast Tumors Trial in Dnipro, Kyiv (Axitinib)

      Enrolling by invitation
      • Breast Cancer
      • +7 more
      • Dnipro, Ukraine
      • +1 more
      Jun 17, 2023

      Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (Adavosertib)

      Active, not recruiting
      • Advanced Lymphoma
      • +5 more
      • Philadelphia, Pennsylvania
        ECOG-ACRIN Cancer Research Group
      Jun 28, 2022

      Pancreatic Adenocarcinoma Metastatic, BRCA1 Mutation, BRCA2 Mutation Trial in Boston, New York (Melphalan, BCNU, Vitamin B12B)

      Recruiting
      • Pancreatic Adenocarcinoma Metastatic
      • +14 more
      • Boston, Massachusetts
      • +1 more
      Dec 6, 2022

      Prospective Research of Outcomes After Salpingo-oophorectomy

      Active, not recruiting
      • BRCA1 Gene Mutation
      • BRCA2 Gene Mutation
        • San Francisco, California
          University of California, San Francisco
        Mar 21, 2022

        Searching for Novel Germline Mutations in Lobular Breast Cancer

        Recruiting
        • Lobular Breast Carcinoma
        • +3 more
        • Illumina panel
        • Milan, Italy
          European Institute of Oncology
        Sep 12, 2022

        l, Laboratory and Epidemiologic Characterization of Individuals

        Completed
        • Familial Ovarian Cancer
        • +3 more
          • Bethesda, Maryland
            National Institutes of Health Clinical Center
          Dec 31, 2022

          Advanced Malignant Tumor, ATM Gene Mutation, BRCA1 Gene Mutation Trial in Houston (Laboratory Biomarker Analysis,

          Active, not recruiting
          • Advanced Malignant Neoplasm
          • +7 more
          • Laboratory Biomarker Analysis
          • +2 more
          • Houston, Texas
            M D Anderson Cancer Center
          Feb 21, 2022